NewAmsterdam Pharma Company NV Ordinary Shares

Price & Volume

Stats

See more
52W Range
$10.50-$27.29
Market Cap
$2.2B
Shares Short
2M

Financials

See more
Revenue (12 Mos)
$33.5M
Revenue Growth (YoY)
889.8%
Gross Profit (12 Mos)
$0
Diluted EPS
-$2.21

About

CEO
Dr. Michael Harvey Davidson FACC, Facp., M.D.
Address
Gooimeer 2-35, Naarden, Netherlands, 1411 DC
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
62